Tiago Fauth

Stock Analyst at Wells Fargo

(2.11)
# 2,998
Out of 5,042 analysts
151
Total ratings
40%
Success rate
-5.25%
Average return

Stocks Rated by Tiago Fauth

Wave Life Sciences
Sep 4, 2025
Maintains: Overweight
Price Target: $21$18
Current: $7.13
Upside: +152.45%
United Therapeutics
Sep 3, 2025
Maintains: Equal-Weight
Price Target: $295$414
Current: $418.58
Upside: -1.09%
MannKind
Sep 3, 2025
Maintains: Overweight
Price Target: $9$10
Current: $5.31
Upside: +88.32%
Insmed
Sep 3, 2025
Maintains: Overweight
Price Target: $140$171
Current: $159.66
Upside: +7.10%
PTC Therapeutics
Aug 20, 2025
Maintains: Overweight
Price Target: $79$73
Current: $66.40
Upside: +9.94%
Liquidia
Aug 13, 2025
Maintains: Overweight
Price Target: $25$31
Current: $22.38
Upside: +38.52%
Alnylam Pharmaceuticals
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $333$395
Current: $463.43
Upside: -14.77%
Ultragenyx Pharmaceutical
Jul 10, 2025
Maintains: Overweight
Price Target: $88$65
Current: $33.53
Upside: +93.86%
BridgeBio Pharma
Jun 30, 2025
Maintains: Overweight
Price Target: $67$76
Current: $54.26
Upside: +40.07%
Savara
May 28, 2025
Maintains: Overweight
Price Target: $8$7
Current: $4.36
Upside: +60.55%
Maintains: Overweight
Price Target: $112$101
Current: $17.15
Upside: +488.92%
Maintains: Equal-Weight
Price Target: $4$3
Current: $1.81
Upside: +65.75%
Maintains: Overweight
Price Target: $28$26
Current: $15.04
Upside: +72.87%
Maintains: Overweight
Price Target: $18$17
Current: $8.67
Upside: +96.08%
Initiates: Overweight
Price Target: $75
Current: $85.63
Upside: -12.41%
Maintains: Outperform
Price Target: $63$62
Current: $5.81
Upside: +967.13%
Assumes: Neutral
Price Target: $89
Current: $202.00
Upside: -55.94%
Assumes: Outperform
Price Target: $51
Current: $22.16
Upside: +130.14%
Assumes: Outperform
Price Target: $120
Current: $54.48
Upside: +120.26%
Reiterates: Underperform
Price Target: $4
Current: $18.94
Upside: -78.88%
Reiterates: Outperform
Price Target: $14
Current: $4.27
Upside: +227.87%
Reiterates: Outperform
Price Target: $300
Current: $133.24
Upside: +125.16%
Reiterates: Outperform
Price Target: $26
Current: $9.70
Upside: +168.04%
Maintains: Outperform
Price Target: $34$28
Current: $5.66
Upside: +394.70%
Maintains: Neutral
Price Target: $70$81
Current: $28.17
Upside: +187.54%
Reiterates: Neutral
Price Target: $8
Current: $0.76
Upside: +952.63%
Reiterates: Outperform
Price Target: $14
Current: $3.46
Upside: +304.62%
Maintains: Outperform
Price Target: $38$34
Current: $1.75
Upside: +1,842.86%
Reiterates: Outperform
Price Target: $150
Current: $8.43
Upside: +1,679.36%
Initiates: Outperform
Price Target: $29
Current: $38.72
Upside: -25.10%
Initiates: Outperform
Price Target: $13
Current: $1.63
Upside: +697.55%
Downgrades: Neutral
Price Target: $25$13
Current: $3.72
Upside: +249.46%
Maintains: Underperform
Price Target: $2.5$2
Current: $1.40
Upside: +42.86%
Maintains: Neutral
Price Target: $297$340
Current: $817.32
Upside: -58.40%
Maintains: Outperform
Price Target: $265$259
Current: $291.76
Upside: -11.23%